Annexon biosciences to participate in 2023 jefferies london healthcare conference

Brisbane, calif., nov. 09, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devasting inflammatory-related diseases, today announced that douglas love, president and chief executive officer, will participate in a fireside chat during the 2023 jefferies london healthcare conference on wednesday, november 15, 2023 at 10:30 a.m. gmt in london.
ANNX Ratings Summary
ANNX Quant Ranking